It’s Not East Being Green: The FDA’s Duties Under NEPA and ESA When Approving New Drugs and Biological Products
Harvard Environmental Law Review
Publication
August 5, 2024
Please visit Harvard Environmental Law Review to view this article.
Related Practices
RELATED PEOPLE
Associate
YOU MIGHT ALSO LIKE
Bilzin Sumberg Partner Eric Singer has been named as Connect CRE's 2025 Lawyers in Real Estate, recognizing his leadership in high-stakes P3 and mixed-use developments.
Bilzin Sumberg congratulates CEO and Managing Partner Albert E. Dotson, Jr. on being named among South Florida Business Journal’s 2025 Ultimate CEO Award honorees.
Kelly Ruane Melchiondo moderates a discussion on innovative development strategies, impactful design, and new approaches to project delivery during the panel “Disruptive Development: Breakthroughs in Concept, Design & Execution” at Bisnow’s 2025 South Florida Construction &...